Kelly Blackburn
Directeur Technique/Scientifique/R&D chez CERVOMED INC.
Fortune : 258 986 $ au 31/05/2024
Postes actifs de Kelly Blackburn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CERVOMED INC. | Directeur Technique/Scientifique/R&D | 16/08/2023 | - |
Bach Pharma, Inc.
 Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Bach Pharma, Inc. is a private company dedicated to developing new therapeutics for the treatment of life-threatening neurodegenerative diseases. The company is based in North Andover, MA. Recently, the company has been encouraged by the effects of GVT on COVID-19 and a recent study found the effectiveness of GVT in Gulf War illness. Bach Pharma's GVT has also been featured in a Texas A&M publication. Kelly Blackburn has been the CEO of the company since 2016. | Directeur/Membre du Conseil | 15/07/2016 | - |
| Directeur Général | 15/07/2016 | - |
Historique de carrière de Kelly Blackburn
Anciens postes connus de Kelly Blackburn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ATYR PHARMA, INC. | Directeur Technique/Scientifique/R&D | 14/08/2013 | 01/07/2016 |
| VERTEX, INC. | Directeur Technique/Scientifique/R&D | 01/09/2006 | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/09/2002 | 01/08/2006 |
Formation de Kelly Blackburn
| University of New Hampshire | Undergraduate Degree |
| Cambridge College Lima SRL | Graduate Degree |
| Quinnipiac College, Inc. | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Pérou | 2 |
| 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| VERTEX, INC. | Technology Services |
| Entreprise privées | 3 |
|---|---|
Bach Pharma, Inc.
Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Bach Pharma, Inc. is a private company dedicated to developing new therapeutics for the treatment of life-threatening neurodegenerative diseases. The company is based in North Andover, MA. Recently, the company has been encouraged by the effects of GVT on COVID-19 and a recent study found the effectiveness of GVT in Gulf War illness. Bach Pharma's GVT has also been featured in a Texas A&M publication. Kelly Blackburn has been the CEO of the company since 2016. | Health Technology |
| CervoMed, Inc. | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Kelly Blackburn
- Expérience
